TP53 Gene Polymorphism Modulates Bladder Cancer Incidence、Invasiveness and Prognosis
博士 === 高雄醫學大學 === 醫學研究所 === 100 === The TP53 gene is a tumor suppressor gene that acts as "guardian of the genome." Loss of p53 function confers genomic instability, impaired apoptosis and diminished cell cycle restraint. Alteration of p53 is the most common mutation in human cancer. Rough...
Main Authors: | Hung-Yu Lin, 林鴻裕 |
---|---|
Other Authors: | Chun-Hsiung Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/44410117626234122572 |
Similar Items
-
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
by: Takashi Kawahara, et al.
Published: (2019-01-01) -
TP53 and XRCC1 polymorphisms and breast cancer prognosis: a case-case study
by: Marina Silva Rodrigues, et al.
Published: (2011-01-01) -
TP53 and MDM2 alterations in human bladder cancer
by: Abdel-Fattah, Rana
Published: (1997) -
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01) -
TP53 (RS1042522) Polymorphism In Breast Cancer
by: Nihal Üren, et al.
Published: (2016-01-01)